lupus nephritis

Pharma

FDA official chastises Aurinia med in now-deleted LinkedIn post

In a now-deleted LinkedIn post, the CDER's chief claimed that Lupkynis carries “significant toxicity” despite failing to show direct clinical benefit.

Fraiser Kansteiner Sep 30, 2025 10:15am

Roche's Gazyva succeeds in key lupus nephritis trial

Feb 7, 2025 11:14am

Roche's Gazyva chases new kidney disease use with phase 3 win

Sep 26, 2024 11:30am

Aurinia brings singer Toni Braxton to Lupus Awareness Month push

May 1, 2024 9:15am

Aurinia quells investor unrest, names former CEO Foster to board

Sep 21, 2023 10:55am

GSK taps social media influencers to reach lupus community

Jul 21, 2023 4:00am